{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:04:07Z","timestamp":1790841847076,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/nm.4247","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T16:32:59Z","timestamp":1481560379000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":228,"title":["Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia"],"prefix":"10.1038","volume":"23","author":[{"given":"Stefanie","family":"G\u00f6llner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Oellerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchi","family":"Agrawal-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Lerdrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigal","family":"Tavor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"St\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Ehninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Urlaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-0788","authenticated-orcid":false,"given":"Martin","family":"Dugas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Spiekermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binje","family":"Vick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1773-7677","authenticated-orcid":false,"given":"Irmela","family":"Jeremias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang E","family":"Berdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Zelent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Wickenhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz P","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"M\u00fcller-Tidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,12]]},"reference":[{"key":"BFnm4247_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/asheducation-2011.1.43","volume":"2011","author":"GJ Roboz","year":"2011","unstructured":"Roboz, G.J. Novel approaches to the treatment of acute myeloid leukemia. Hematology Am. Soc. Hematol. Educ. Program 2011, 43\u201350 (2011).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"BFnm4247_CR2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nm.2661","volume":"18","author":"T Schenk","year":"2012","unstructured":"Schenk, T. et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 18, 605\u2013611 (2012).","journal-title":"Nat. Med."},{"key":"BFnm4247_CR3","first-page":"863","volume":"108","author":"U Krug","year":"2011","unstructured":"Krug, U., B\u00fcchner, T., Berdel, W.E. & M\u00fcller-Tidow, C. The treatment of elderly patients with acute myeloid leukemia. Dtsch. Arztebl. Int. 108, 863\u2013870 (2011).","journal-title":"Dtsch. Arztebl. Int."},{"key":"BFnm4247_CR4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ng.2913","volume":"46","author":"B Knoechel","year":"2014","unstructured":"Knoechel, B. et al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat. Genet. 46, 364\u2013370 (2014).","journal-title":"Nat. Genet."},{"key":"BFnm4247_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma, S.V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69\u201380 (2010).","journal-title":"Cell"},{"key":"BFnm4247_CR6","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2011-07-367961","volume":"119","author":"AF Ribeiro","year":"2012","unstructured":"Ribeiro, A.F. et al. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood 119, 5824\u20135831 (2012).","journal-title":"Blood"},{"key":"BFnm4247_CR7","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1182\/blood-2011-02-339747","volume":"118","author":"WC Chou","year":"2011","unstructured":"Chou, W.C. et al. TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics. Blood 118, 3803\u20133810 (2011).","journal-title":"Blood"},{"key":"BFnm4247_CR8","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1182\/blood-2011-08-368225","volume":"118","author":"KH Metzeler","year":"2011","unstructured":"Metzeler, K.H. et al. ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category. Blood 118, 6920\u20136929 (2011).","journal-title":"Blood"},{"key":"BFnm4247_CR9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","volume":"42","author":"T Ernst","year":"2010","unstructured":"Ernst, T. et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 42, 722\u2013726 (2010).","journal-title":"Nat. Genet."},{"key":"BFnm4247_CR10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","volume":"12","author":"AH Shih","year":"2012","unstructured":"Shih, A.H., Abdel-Wahab, O., Patel, J.P. & Levine, R.L. The role of mutations in epigenetic regulators in myeloid malignancies. Nat. Rev. Cancer 12, 599\u2013612 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm4247_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343\u2013349 (2011).","journal-title":"Nature"},{"key":"BFnm4247_CR12","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/MCB.21.13.4330-4336.2001","volume":"21","author":"D O'Carroll","year":"2001","unstructured":"O'Carroll, D. et al. The polycomb-group gene Ezh2 is required for early mouse development. Mol. Cell. Biol. 21, 4330\u20134336 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm4247_CR13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","volume":"42","author":"G Nikoloski","year":"2010","unstructured":"Nikoloski, G. et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet. 42, 665\u2013667 (2010).","journal-title":"Nat. Genet."},{"key":"BFnm4247_CR14","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1182\/blood-2011-06-363424","volume":"118","author":"P Guglielmelli","year":"2011","unstructured":"Guglielmelli, P. et al. EZH2 mutational status predicts poor survival in myelofibrosis. Blood 118, 5227\u20135234 (2011).","journal-title":"Blood"},{"key":"BFnm4247_CR15","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1038\/ncomms5177","volume":"5","author":"G Sashida","year":"2014","unstructured":"Sashida, G. et al. Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation. Nat. Commun. 5, 4177 (2014).","journal-title":"Nat. Commun."},{"key":"BFnm4247_CR16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624\u2013629 (2002).","journal-title":"Nature"},{"key":"BFnm4247_CR17","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/ncomms7051","volume":"6","author":"D Zingg","year":"2015","unstructured":"Zingg, D. et al. The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nat. Commun. 6, 6051 (2015).","journal-title":"Nat. Commun."},{"key":"BFnm4247_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","volume":"21","author":"BG Bitler","year":"2015","unstructured":"Bitler, B.G. et al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat. Med. 21, 231\u2013238 (2015).","journal-title":"Nat. Med."},{"key":"BFnm4247_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin, R.D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42, 181\u2013185 (2010).","journal-title":"Nat. Genet."},{"key":"BFnm4247_CR20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade, D. et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116, 354\u2013365 (2010).","journal-title":"Blood"},{"key":"BFnm4247_CR21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","volume":"22","author":"O Abdel-Wahab","year":"2012","unstructured":"Abdel-Wahab, O. et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 22, 180\u2013193 (2012).","journal-title":"Cancer Cell"},{"key":"BFnm4247_CR22","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2009-03-213496","volume":"114","author":"W Fiskus","year":"2009","unstructured":"Fiskus, W. et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood 114, 2733\u20132743 (2009).","journal-title":"Blood"},{"key":"BFnm4247_CR23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00277-009-0889-1","volume":"89","author":"F St\u00f6lzel","year":"2010","unstructured":"St\u00f6lzel, F. et al. Mechanisms of resistance against PKC412 in resistant FLT3-ITD positive human acute myeloid leukemia cells. Ann. Hematol. 89, 653\u2013662 (2010).","journal-title":"Ann. Hematol."},{"key":"BFnm4247_CR24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood-2005-06-2469","volume":"107","author":"F Heidel","year":"2006","unstructured":"Heidel, F. et al. Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain. Blood 107, 293\u2013300 (2006).","journal-title":"Blood"},{"key":"BFnm4247_CR25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1172\/JCI6863","volume":"104","author":"F Bunz","year":"1999","unstructured":"Bunz, F. et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104, 263\u2013269 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnm4247_CR26","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4247_CR27","doi-asserted-by":"crossref","first-page":"12223","DOI":"10.1073\/pnas.91.25.12223","volume":"91","author":"G Sauvageau","year":"1994","unstructured":"Sauvageau, G. et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA 91, 12223\u201312227 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4247_CR28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0037-1963(03)00196-3","volume":"40","author":"SA Armstrong","year":"2003","unstructured":"Armstrong, S.A., Golub, T.R. & Korsmeyer, S.J. MLL-rearranged leukemias: insights from gene expression profiling. Semin. Hematol. 40, 268\u2013273 (2003).","journal-title":"Semin. Hematol."},{"key":"BFnm4247_CR29","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1073\/pnas.96.25.14372","volume":"96","author":"RD Hanson","year":"1999","unstructured":"Hanson, R.D. et al. Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. Proc. Natl. Acad. Sci. USA 96, 14372\u201314377 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4247_CR30","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/bioinformatics\/btu003","volume":"30","author":"HU Klein","year":"2014","unstructured":"Klein, H.U. et al. Integrative analysis of histone ChIP-seq and transcription data using Bayesian mixture models. Bioinformatics 30, 1154\u20131162 (2014).","journal-title":"Bioinformatics"},{"key":"BFnm4247_CR31","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","DOI":"10.1056\/NEJMoa1301689"},{"key":"BFnm4247_CR32","doi-asserted-by":"crossref","first-page":"28511","DOI":"10.1074\/jbc.M111.240515","volume":"286","author":"SC Wu","year":"2011","unstructured":"Wu, S.C. & Zhang, Y. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J. Biol. Chem. 286, 28511\u201328519 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnm4247_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ncb2139","volume":"13","author":"Y Wei","year":"2011","unstructured":"Wei, Y. et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat. Cell Biol. 13, 87\u201394 (2011).","journal-title":"Nat. Cell Biol."},{"key":"BFnm4247_CR34","doi-asserted-by":"crossref","first-page":"35194","DOI":"10.1074\/jbc.273.52.35194","volume":"273","author":"S Chen","year":"1998","unstructured":"Chen, S. & Smith, D.F. Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90 chaperone machinery. J. Biol. Chem. 273, 35194\u201335200 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnm4247_CR35","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1073\/pnas.0903392106","volume":"106","author":"E Caldas-Lopes","year":"2009","unstructured":"Caldas-Lopes, E. et al. Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models. Proc. Natl. Acad. Sci. USA 106, 8368\u20138373 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4247_CR36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35056563","volume":"2","author":"AM Weissman","year":"2001","unstructured":"Weissman, A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2, 169\u2013178 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnm4247_CR37","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2015-11-683649","volume":"127","author":"C Pabst","year":"2016","unstructured":"Pabst, C. et al. GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo. Blood 127, 2018\u20132027 (2016).","journal-title":"Blood"},{"key":"BFnm4247_CR38","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2013.80","volume":"27","author":"SN Khan","year":"2013","unstructured":"Khan, S.N. et al. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia 27, 1301\u20131309 (2013).","journal-title":"Leukemia"},{"key":"BFnm4247_CR39","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","volume":"125","author":"RC Lindsley","year":"2015","unstructured":"Lindsley, R.C. et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood 125, 1367\u20131376 (2015).","journal-title":"Blood"},{"key":"BFnm4247_CR40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner, H. et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115, 453\u2013474 (2010).","journal-title":"Blood"},{"key":"BFnm4247_CR41","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","volume":"119","author":"H Makishima","year":"2012","unstructured":"Makishima, H. et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 119, 3203\u20133210 (2012).","journal-title":"Blood"},{"key":"BFnm4247_CR42","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1182\/blood-2011-11-390252","volume":"119","author":"SJ Zhang","year":"2012","unstructured":"Zhang, S.J. et al. Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome. Blood 119, 4480\u20134485 (2012).","journal-title":"Blood"},{"key":"BFnm4247_CR43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1200\/JCO.2012.45.2177","volume":"31","author":"EC Attar","year":"2013","unstructured":"Attar, E.C. et al. Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502. J. Clin. Oncol. 31, 923\u2013929 (2013).","journal-title":"J. Clin. Oncol."},{"key":"BFnm4247_CR44","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","volume":"113","author":"J Faber","year":"2009","unstructured":"Faber, J. et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 113, 2375\u20132385 (2009).","journal-title":"Blood"},{"key":"BFnm4247_CR45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nmeth.2847","volume":"11","author":"C Pabst","year":"2014","unstructured":"Pabst, C. et al. Identification of small molecules that support human leukemia stem cell activity ex vivo. Nat. Methods 11, 436\u2013442 (2014).","journal-title":"Nat. Methods"},{"key":"BFnm4247_CR46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nchembio.1331","volume":"9","author":"W Kim","year":"2013","unstructured":"Kim, W. et al. Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer. Nat. Chem. Biol. 9, 643\u2013650 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"BFnm4247_CR47","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/pmic.201300035","volume":"13","author":"I Atanassov","year":"2013","unstructured":"Atanassov, I. & Urlaub, H. Increased proteome coverage by combining PAGE and peptide isoelectric focusing: comparative study of gel-based separation approaches. Proteomics 13, 2947\u20132955 (2013).","journal-title":"Proteomics"},{"key":"BFnm4247_CR48","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"BFnm4247_CR49","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794\u20131805 (2011).","journal-title":"J. Proteome Res."},{"key":"BFnm4247_CR50","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","volume":"1","author":"A Shevchenko","year":"2006","unstructured":"Shevchenko, A., Tomas, H., Havlis, J., Olsen, J.V. & Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856\u20132860 (2006).","journal-title":"Nat. Protoc."},{"key":"BFnm4247_CR51","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1182\/blood-2014-06-585216","volume":"125","author":"T Oellerich","year":"2015","unstructured":"Oellerich, T. et al. FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation. Blood 125, 1936\u20131947 (2015).","journal-title":"Blood"},{"key":"BFnm4247_CR52","first-page":"47","volume":"24","author":"C H\u00f6mme","year":"2010","unstructured":"H\u00f6mme, C. et al. Low SMC1A protein expression predicts poor survival in acute myeloid leukemia. Oncol. Rep. 24, 47\u201356 (2010).","journal-title":"Oncol. Rep."},{"key":"BFnm4247_CR53","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele, W. & Stegner, H.E. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8, 138\u2013140 (1987).","journal-title":"Pathologe"},{"key":"BFnm4247_CR54","doi-asserted-by":"crossref","first-page":"e0120925","DOI":"10.1371\/journal.pone.0120925","volume":"10","author":"B Vick","year":"2015","unstructured":"Vick, B. et al. An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging. PLoS One 10, e0120925 (2015).","journal-title":"PLoS One"},{"key":"BFnm4247_CR55","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"BFnm4247_CR56","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","volume":"25","author":"K Ye","year":"2009","unstructured":"Ye, K., Schulz, M.H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865\u20132871 (2009).","journal-title":"Bioinformatics"},{"key":"BFnm4247_CR57","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07107","volume":"454","author":"A Meissner","year":"2008","unstructured":"Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766\u2013770 (2008).","journal-title":"Nature"},{"key":"BFnm4247_CR58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2012-08-448860","volume":"121","author":"T Schoofs","year":"2013","unstructured":"Schoofs, T. et al. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding. Blood 121, 178\u2013187 (2013).","journal-title":"Blood"},{"key":"BFnm4247_CR59","doi-asserted-by":"crossref","first-page":"e1002494","DOI":"10.1371\/journal.pgen.1002494","volume":"8","author":"N Dietrich","year":"2012","unstructured":"Dietrich, N. et al. REST-mediated recruitment of polycomb repressor complexes in mammalian cells. PLoS Genet. 8, e1002494 (2012).","journal-title":"PLoS Genet."},{"key":"BFnm4247_CR60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nsmb.3180","volume":"23","author":"M Lerdrup","year":"2016","unstructured":"Lerdrup, M., Johansen, J.V., Agrawal-Singh, S. & Hansen, K. An interactive environment for agile analysis and visualization of ChIP-sequencing data. Nat. Struct. Mol. Biol. 23, 349\u2013357 (2016).","journal-title":"Nat. Struct. Mol. Biol."}],"updated-by":[{"DOI":"10.1038\/s41591-025-04159-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm.4247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.4247","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.4247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:05:07Z","timestamp":1767791107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,12]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFnm4247"],"URL":"https:\/\/doi.org\/10.1038\/nm.4247","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,12]]},"assertion":[{"value":"11 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41591-025-04159-8","URL":"https:\/\/doi.org\/10.1038\/s41591-025-04159-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}